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ABSTRACT
Baculovirus surface display has been employed as an excellent  tools for presentation of foreign peptides and
proteins on virus surface with native conformation, functions and immunogenicity. A baculovirus major envelope
protein, gp64, or a capsid protein, vp39 are generally used as fusion partners for displaying of polypeptides on the
surface of virions. Alternatively, a membrane anchoring domain of vesicular stomatitis virus G protein (VSV-G)
can also be used. In this study, an influenza neuraminidase (NA) was proposed as a new membrane anchor for
the display of Angiotensin II (AngII), DRVYIHPFHL, peptides. The AngII peptides were inserted into NA by
replacing  NA  amino  acid  number  60-67  with  AngII,  and  then  integrated  into  a  baculovirus  genome.  A
recombinant baculovirus expressing the NA fusion-AngII peptides was generated from infected insect cells. Those
peptides were found to express and translocated on the membrane of the baculovirus infected insect cell (Sf9 cell)
as detected by immunocytochemistry using anti-AngII monoclonal antibody. Upon budding of the recombinant
baculovirus progenies through the insect cells membrane, the recombinant NA-AngII peptides was acquired to
envelopes of the new baculovirus progenies. The conformation of NA on baculovirus surface was not affected by
the deletion, as the 55 kDa band of NA can be detected from Western Blotting analysis by specific anti-NA
monoclonal antibody. In addition, the same protein was also found by anti-AngII antibody indicating that the
AngII peptides had been successfully fused with the recombinant NA. Interestingly, electron microscopy analysis
demonstrated that not only the recombinant baculovirus displaying AngII peptides were generated by infected
insect cells, but also the NA virus-like-particle displaying AngII peptides. 
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Baculovirus, an insect virus has been widely used as
an expression system [1]. Baculovirus is able to trans-
duce  a  broad  range  of  mammalian  and  avian  cells,
therefore, it also potentially be used as gene delivery
vector [2]. Interestingly, foreign protein can be manip-
ulated to be displayed on baculovirus  surface.  It  has
been reported that baculovirus surface display is poten-
tially be used as an efficient vaccine, such as vaccine
against classical swine fewer virus [3], malaria [4] and
human enterovirus 71 (EV71) [5].
The display of antigen on baculovirus surface can
be facilitated by fusion of antigen with gp64 protein
which  is  the  major  envelope  protein  of  Baculovirus.
Gp64 comprised of amino acid signal peptide domain,
carboxyl  proximal  transmembrane  domain  and  cyto-
plasmic  tail  domain.  After  gp64  expression,  it  will
translocate to host cell membrane that control by sig-
nal peptide domain. During virus budding, the virion
will take up proteins from host cell membrane to gen-
erate envelope protein, consequently, the gp64 will be
incorporated  in  baculovirus  envelope  [6].  However,
low number of gp64 fusion protein can be incorporated
into viral membrane due to competition of fusion gp64
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and wild type gp64 to be uptake by virion during virus
budding [7]. 
Thus, some other transmembrane proteins such as
vesicular somatic virus glycoprotein (VSVG) has been
used as an alternative. The VSVG membrane anchor
approach provides higher level of display of GFP pro-
tein on baculovirus in comparison with that of gp64
fusion protein base [8]. In addition, Kolpe et al. (2012)
reported that  VP1 of human enterovirus 71 together
with signal peptide and transmembrane domain of in-
fluenza neuraminidase (NA) can be displayed on bac-
ulovirus surface [5]. NA signal peptide and transmem-
brane domain fusion protein seems to have a non-polar
virus distribution, unlike gp64 fusion protein that lim-
ited to the pole of baculovirus [9].
In this study, a modified full length NA fused with
AngII  peptide  was  shown  to  be  displayed  on  bac-
ulovirus  surface  as  fusion peptide.  Furthermore,  NA
virus like particle (VLP) was also produced with AngII
displayed on its surface.
Cells and virus
The  Spodoptera frugiperda (Sf-9)  insect  cells  line
(ATCC,  USA)  were  grown as  suspension  culture  in
TMN-FH medium (Gibco,  USA)  supplemented with
10%  heat  inactivated  fetal  bovine  serum  (Hyclone,
USA).  Recombinant  baculoviruses  were  amplified  in
Sf-9 cells according to Bac to Bac manual (Invitrogen,
USA). The virus titter was determined by end point di-
lution assay [10]. 
Generation of recombinant baculovirus displaying NA-
AngII
Recombinant baculovirus was generated according
to Bac to Bac system protocol (Invitrogen, USA). A re-
combinant  donor  plasmid  pFASTBac_ie1_na-angII
was constructed by insertion of White Spot Syndrome
Virus ie1 promoter (IE1) and na_angII into pFAST-
BacHT A, baculovirus transfer vector with polyhedron
promoter (Invitrogen, USA). Firstly, the pFASTBacHT-
A polyhedrin promoter was removed and replaced with
a PCR amplified ie1 promoter of WSSV. WSSV IE1
promoter was amplified by using IE1 specific primer,
IE1F-5’-GTGCGTACGTAGGCTGTTTGAATCAT-
GTTAAGG-3’ and IE1 R-5’ATTAGGCGCC TATCG-
GACCGCTTGAGTGGAGAGAGAGA-3’,
pBACsurf_IE1was used as template.
AngII  was  inserted  into  influenza Neuraminidase
(NA) at amino acid number 60 by overlapping PCR
using  pGEM-NA  vector  as  template.  After  second
Figure 1. Recombinant  donor  plasmid  pFastBac_ie1_na-
angII
round PCR, the full length NA-AngII with size of 1380
bp was generated.
The amplified PCR products were then clones into
SnaBI  and  RsrII  restriction  enzyme  into
pFASTBac_ie1.  The pFASTBac_ie1_na-angII  recom-
binant  donor  plamid  (figure  1)  was  then  integrated
into  a  baculovirus  DNA  (bacmid)  in  DH10BacTM
through  site-specific  transposition.  The  positive
DH10Bac E. coli colonies were selected by blue/white
colony  selection.  The  recombinant  bacmid  with  ie1
promoter and na_angII was then extracted from white
colony and was transfected into Sf-9 cells by using cell-
fectin  II  (Invitrogen,  USA)  to  generate  recombinant
baculovirus, rBV_IE1_NA-AngII.
rBV_IE1_NA-AngII production
rBV_IE1_NA-AngII  was  produced  by  infecting
into Sf9 cells at multiplicity of infection (MOI) of 0.1
and harvested after 5 days post infections. The virus
was collected by overlaying onto 30% sucrose and ul-
tracentrifugation at 26,500 rpm for 1.5 hour. The virus
pellet was resuspended in PBS. 
NA-AngII gene expression 
To  verify  the  expression  of  NA-AngII  in  insect
cells, total RNA from infected Sf-9 cells was extracted
by TRIZOL reagent (Invitrogen, USA) and cDNA was
prepared according to manufacture protocol (Thermo
scientific,  USA).  Twenty  nanogram  of  synthesized
cDNA was used as template for DNA amplification us-
ing primers specific to NA sequences and AngII.
Immuno-fluorescent analysis
Sf-9 cells were seeded in 12-well plate at cell density
of  1  × 106 cells  per  well  and  infected  with
rBV_IE1_NA-AngII at MOI 0.1 for 48 hour at 27°C.
The culture medium was removed and infected cells
were washed 3 times with PBS. The anti-NA and/or
anti-AngII antibodies at a dilution of 1 : 1000 was used
as primary antibody and a goat anti-rabbit IgG conju-
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gated with green fluorescence at dilution of 1 :  5000
were used as secondary antibody.  The green fluores-
cence on the infected cells membrane were detected us-
ing fluorescence microscopy IX71 (Olympus, Japan)
Western blot analysis
The  concentrated  rBV_IE1_NA-AngII  was  sub-
jected to 12% SDS-PAGE (Amersham, UK) and trans-
ferred to nitrocelullose membrane (Bio-Rad, USA). The
anti-NA and/or anti-AngII monoclonal antibodies at a
dilution of  1:500 was  used as  primary  antibody and
goat anti-rabbit IgG conjugated with horseradish per-
oxidase (HRP) at dilution of 1:5000 was used as sec-
ondary antibody. For signal detection, the protein band
was  developed  by  3,3 ,5,5 -Tetramethylbenzidine′ ′
(TMB) liquid substrate  (Sigma, USA). 
Transmission electron microscope analysis
Carbon coated grids (EMS, USA) were floated on
concentrated rBV_IE1_NA-AngII solution for 30 min,
washed with 5 drops of deionized water and negatively
stained with 2% uranyl acetate solution (Sigma, USA)
and examined under transmission electron microscope
HT7700 (Hitachi, Japan). 
Construction  of  recombinant  baculovirus  displaying
NA-AngII
AngII peptides, an eight amino acid peptide that re-
sponsible  in  controlling  blood pressure  in  renin  an-
giotensin system [11] was chosen as model peptides to
be displayed by fusion with influenza neuraminidase
(NA) and displayed on baculovirus surface. The shuttle
promoter  that  active  in  both  insect  and mammalian
cells, IE1 [12], was chosen to control NA-AngII gene
expression.  The  NA  fragment  used  for  fusion  with
AngII consists of a signal peptides, a trans-membrane
region, a          hypervariable stalk and a globular do-
main to facilitate the display of AngII on baculovirus
surface [13]. 
AngII peptide was inserted into the NA protein be-
tween amino acid residues from 60 to 67. Deletion of
these amino acids at  this region did not not disrupt
NA conformation, in addition, the AngII peptide was
expected to be located on the exposed location [14].
Figure 2a and 2b show introduction of NA-AngII
into  baculovirus  genome.  Firstly,  the  recombinant
transfer vector containing ie1 promoter and NA-AngII
was constructed and transformed into DH10Bac E. coli
containing baculovirus genome (bacmid).  By site spe-
cific transposition, the NA-AngII under the control of 
(a)
           (b)            (c)
Figure 2. (a) Recombinant transfer vector, (b) Transposition
of ie1-na-angII  into baculovirus  genome (bacmid)
(c) PCR analysis of recombinant bacmid using M13
(LacZ) specific primers. Lane 1: 2 long DNA ladder,
2:  Negative  control  of  PCR  product  using  M13
primer and 3 and 4: PCR product of recombinant
bacmid  with  ie1-na-angII  insertion  using  M13
primer.
Figure 3. Sf-9 cell at 72 days in culture (a) and transfected Sf-
9 cells at 72 hours (b)
          
ie1 promoter was transferred to bacmid according to
Bac to Bac system (Invitrogen, USA) at LacZ. Thus, re-
combinants  baculoviru  DH10Bac  colonies  become
white when cultured on the LB containing X-gal (sub-
strate to produce a blue product). The white colonies
were then selected for extraction of the recombinant
bacmid DNA.
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Figure 4.  Reverse transcriptase PCR using NA specific primer
(Lane 1-4) and NA, AngII specific primer (Lane 5-
7) for detection of NA-AngII expression in infected
cell with rBV_IE1_NA-AngII. Lane 1: 2log DNA
ladder, 2 and 5: negative control without template,
3  and  6:  pFASTBac_ie1_NA-AngII  was  used  as
template for positive control, 4 and 7: synthesized
cDNA from infected cell was used as template 
Figure 5.  NA-AngII fusion protein on infected Sf-9 cell mem-
brane.  Cells  were  infected  with  wild  type  bac-
ulovirus,  AcMNPV  and  recombinant  baculovirus
rBV_IE1_NA-AngII. 48 hours after infections, the
infected cells were analyzed by immuno-flourescent
using anti-NA specific antibody (A) and anti-AngII
specific antibody (B), followed secondary antibody
conjugated with green fluorescent.
The recombinant bacmid NA-AngII was transfected
into Sf-9 insect cells using CellFECTIN II reagent (In-
vitrogen, USA). The recombinant baculovirus was then
harvested from transfected cell culture medium when
cytopathic effect of the Sf-9 insect cell was observed at
72 hour post transfection (Figure 3). 
Expression of NA-AngII fusion gene
Reverse transcriptase PCR was used to verify NA-
AngII expression in infected Sf-9 cell with recombinant
baculovirus,  rBV_IE1_NA-AngII.  Figure  4  shows  a
specific band of PCR product at 1380 bp correspond-
ing to the transcription of NA-AngII,  when the NA
specific primers were used. In addition, specific PCR
product at 201 bp, which represents N-terminal of NA
(59 amino acids) with additional eight amino acids of
AngII could also be detected when the NA specific for-
ward primer  and AngII  specific  reverse  primer  were
used.
Characterization of rBV_IE1_NA-AngII 
In order to confirm the translocation of NA_AngII
to Sf-9 infected cell membrane, the immune-fluorescent
analysis  was  performed.  The Sf-9  cells  were  infected
with  rBV_IE1_NA-AngII  or  wild  type  baculovirus,
AcMNPV (as control) for 48 h. The green fluorescent
were observed from infected cell with rBV-NA_AngII
detected  by  using  anti-NA  antibody  and  anti-AngII
specific monoclonal antibody, while there is no fluores-
cent signal can be observed from infected cells. This in-
dicated  that  the  NA_AngII  has  been  expressed  and
translocated  on  the  infected  cell  membrane,  before
virus budding (Figure 5).
Western blot analysis showed that NA can be de-
tected on baculovirus surface, as the 55 kDa band of
NA can be detected by anti-NA monoclonal antibody.
The same size  of  protein  was also detected by anti-
AngII antibody indicating that the AngII peptides had
been successfully fused with the recombinant NA and
was displayed on baculovirus surface on the exposed
position (Figure 6).
 
Electron micrograph of rBV_IE1_NA-AngII 
Transmission  electron  microscope  was  performed
to observe the budded virus rBV_IE1_NA-AngII that
accumulated in infected cell culture medium. TEM pic-
ture  shows  rod  shapes  rBV_NA_AngII  budded  out
from  infected  cell  and  it  is  expected  to  display
NA_AngII on baculovirus surface. Interestingly, there
are also NA-AngII-Virus Like Particles (VLP) can be
observed in infected cell culture supernatant (Figure 7).
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Figure 6. Western  Blot  analysis  of  recombinant  BV_
IE1_NA-AngII against (a) anti-NA monoclonal an-
tibody and (b) anti-AngII monoclonal antibody (Ar-
row indicate the NA-AngII band).   Lane 1:  Wild
type AcMNPV, 2: rBV_IE1_NA-AngII
Figure 7. rBV- NA_AngII particles under transmission elec-
tron  microscope.  White  arrow  indicate  rBV-
NA_AngII  particle  and  black  arrow  indicated
NA_AngII VLP
This result agree with Lai, et al (2010) that reported
NA play key role in virus budding and it could facili-
tate the formation of NA-VLP which morphologically
similar to influenza virion [15].
AngII peptides has been successfully fused with in-
fluenza neuraminidase and was located on the exposed
position  and  the  recombinant  baculovirus  displaying
NA-AngII antigen on the surface of virus particle was
successfully constructed
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